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Clinical ethics: medical tourism in children  
Paediatricians sometimes learn that parents plan to take a child overseas for medical treatment 
(Box 1). How should they respond? 
Child medical tourism is “the bi-directional movement of children … to and from a country to 
seek advice, diagnosis and treatments”.1 In the UK, it is estimated that (pre COVID) 63,000 
adult patients sought treatment abroad yearly. The number of children (patients <18 years) 
involved in medical tourism is unknown. Decisions to seek treatment abroad are made privately 
by parents and usually uncontested by NHS staff, despite some high-profile court cases. 
[Box 1] 
Child medical tourism happens because parents prefer another health-care system (case A, Box 
1) or want access to therapies unavailable in the UK. Therapies may be unavailable because 
they are experimental (B, C) unlicensed for the indication or parents are unable to find a willing 
prescriber (D), there is disagreement about the child’s best interest (E), or they are illegal (F). 
Treatments range from those involving entirely unverified technologies to others where some 
evidence exists but below best evidence level. Where a ‘medically justifiable’ therapy is 
unavailable in the UK, some funding may be found through the NHS (via the S2 route). In 
many cases parents fund the treatment privately. 
Areas of concern 
Health tourism has been lauded by as a means by which low- and middle-income countries can 
grow develop strong service economies. Nevertheless there are costs for local populations who 
are usually unable to access hospitals and clinicians serving health tourists. While inbound and 
outbound medical tourism for adults has been estimated to be cost neutral to the NHS,2 




abroad could have significant resource implications to the NHS (for example tracheostomy and 
home ventilation). 
Cultures vary in their attitudes toward children and the appropriate limits of medical treatment. 
With variable accreditation, the quality of accessed healthcare treatments also varies. Adults 
have reported high patient satisfaction following treatment overseas, although lack of long term 
follow-up may mask longer term problems. Obtaining redress in cases of treatment failure or 
negligence is tricky, and receiving corrective treatment on the NHS after the child returns home 
is not guaranteed. Treatment abroad often lacks continuity of care, with variable (or absent) 
sharing of medical information between countries if there are problems. 
Because medical treatment is expensive, crowdfunding websites have become a popular 
method of raising funds. The emphasis on public sympathy means that crowdfunding does not 
distribute resources equitably, and minority groups may raise less funds through crowdfunding 
than their non-minority peers.3 Crowdfunding publicises the private health information of a 
child with potentially life-long impacts. Where parents are seeking an ‘innovative’ or unusual 
treatment, there is little consensus about the standards of acceptable treatment in case law. 
Notionally, an acceptable treatment must be adequate on the grounds of evidence, expertise 
and infrastructure,4 yet the courts have sometimes adopted lower standards. 
Despite these concerns, and notwithstanding the risks, seeking treatment for a child abroad is 
not in itself unreasonable. Paediatricians should engage with, educate and support parents to 
make informed decisions in the best interests of the child. 
Recommendations 
Decisions about medical treatment for children are based on their best interests, arrived at 
through a process of shared decision-making with the child’s parents/caregivers. Paediatricians 




their child. Such discussions are only likely if parents perceive the health professionals as open-
minded, supportive and willing to engage in dialogue. Clinicians should empathically explore 
parents’ understanding of a child’s illness and prognosis, their reasons for seeking treatment 
abroad, and their priorities and concerns.    
Doctors in the UK should advise parents and support them where appropriate in identifying 
reputable institutions to perform treatment. A reputable institution should have i) Clinicians 
experienced in giving the proposed therapy; ii) a clear, evidence-based, treatment plan and a 
proven ability to deliver, and; iii) a plan for aftercare and long-term follow up. A reputable 
overseas provider will also have no problem with either involving the parents in planning 
treatment or with forming relationships with UK clinicians to deliver long-term follow-up. 
Where families seeking overseas care are making a reasonable choice, clinicians should support 
best medical care by referring directly to the overseas institution. Where there are poor 
standards of information from institutions whose business is medical tourism, these institutions 
should be treated with suspicion. Parents should be encouraged to find different providers if 
there are concerns about an institution’s approach. 
Without jeopardising engagement with parents, doctors should ensure that parents are aware 
of their limited legal redress if things go wrong, even from ‘safe’ destinations within the 
European Economic Area and USA. There is no guarantee that overseas institutions will 
cooperate with the courts or agree that a case for damages will be heard in the UK. Even if it 
is, UK courts are obliged to follow the laws of the destination country. There may be weaker 
protections in negligence cases, with low caps on damages or limits on how long compensation 
may be claimed. Where damages are awarded, it may be impossible to compel overseas 
institutions to pay them.  Depending on what went wrong, it could be difficult to get problems 
treated on the NHS.5 Furthermore, even where treatment commenced overseas is successful it 




the child will be the deciding factor in these cases). Parents should be advised of these 
difficulties so they can make an informed choice. 
Sometimes parents will remain fixed on a treatment that a UK doctor has severe concerns about, 
perhaps because a doctor at the destination makes unlikely claims, a treatment is ineffective, 
appears dangerous or imposes burdens on the child. A key ethical consideration is whether the 
proposed course of action exposes the child to risks of harm that are disproportionate to any 
benefits. If the travel to the proposed destination, treatment, and aftercare is of questionable 
benefit, but low risk, it may be reasonable for parents to pursue it.  
Clinicians have a legal duty of care toward the child. As well as satisfying themselves of the 
reputability of a foreign institution, it may be helpful to seek a second opinion, in order to 
provide parents with an alternative point of view and clarify harms and benefits of the proposed 
treatment. Where the clinician remains concerned about the child’s wellbeing, and engagement 
and second opinions fail, it may be appropriate to involve the courts. Occasionally parents will 
want a treatment that is criminal (e.g. results in significant and foreseeable harms). Parents 
should be aware that circumventing the law will result in prosecution when it comes to light, 
and clinicians must take immediate action to protect the child. 
Conclusion 
Seeking medical treatment abroad is increasingly common and may become more so with the 
emergence of therapies for rare diseases that are expensive and limited in availability. Medical 
tourism raises a range of ethical concerns, but it is not necessarily unreasonable to seek 
treatment for a child abroad. Parents should be supported to make wise and informed choices 





Box 1 Cases of medical tourism in children 
A. A child with severe eczema whose parents are 1st generation immigrants. Parents plan to 
return to their home country for a second opinion. 
B. A child with relapsed malignancy with a short time to live. Parents are planning to take 
abroad for an experimental vitamin therapy. 
C. A child with autism. Parents plan to take overseas for intrathecal stem cell therapy. 
D. A young person with complex epilepsy. Parents planning to take overseas for cannabinoid 
based medications. 
E. A child in a minimally conscious state, ventilated in intensive care. Parents wish to take to 
another country for tracheostomy and ongoing intensive care. 
F. A girl with no medical conditions. Parents plan to take overseas for female circumcision. 
 
 
1 Hamlyn-Williams C, Lakhanpaul M, Manikam L, Child Medical Tourism: A New Phenomenon in  
Lunt N, Horsfall D,Hanefeld J (eds), Handbook on Medical Tourism and Patient Mobility. Cheltenham, UK: 
Edward Elgar Publishing 2015:360.  
2 Hanefeld J, Horsfall D, Lunt N, et al. Medical tourism: a cost or benefit to the NHS? PloS one 
2013;8(10):e70406. doi: 10.1371/journal.pone.0070406 
3 Younkin P, Kuppuswamy V. The Colorblind Crowd? Founder Race and Performance in Crowdfunding. 
Management Science 2018;64(7):3269-87. doi: 10.1287/mnsc.2017.2774 
4 NHS v SR EWHC 3842, 2012 
5 Keyi Sim N. The Travelling Patient: A Clinician's Guide to the Law Surrounding Medical Tourism. Medico-
Legal Journal 2014;82(4):159-63. doi: 10.1177/0025817214526528 
